Sign inJoin waitlistJoin the waitlist

Cynthia Lynch

Medical Director of Breast Program, City of Hope Cancer Center Phoenix · City of Hope National Medical Center

Credentials: · · · · · ·

History

City of Hope Cancer Center Phoenix · City of Hope National Medical Center
Present
Atlanta Cancer Hospital City of Hope
Present

Hematology and Medical Oncology
ECU Health Medical Center
2005–2008
Internal Medicine
Cleveland Clinic Florida
2001–2004
Drexel University College of Medicine
1997–2001
Mansfield University
1993–1997

Research

A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus)
British Journal of Cancer · 2017 · 110 citations
Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance)
Journal of the Neurological Sciences · 2015 · 44 citations
Prospective study of correlations between biopsy-detected high grade prostatic intraepithelial neoplasia, serum prostate specific antigen concentration, and race
Cancer · 2001 · 26 citations

AM
Anastasios Mihas
5 papers
HN
Hussein El Newihi
2 papers
Amit Kulkarni
1 paper · 1 as a resident
AB
Andreas Beutler
1 paper
Ashish Sangal
1 paper
BD
Bernard Dreiling
1 paper
CL
Charles Loprinzi
1 paper
GW
Glen Weiss
1 paper
JN
Jiaxin Niu
1 paper
John Farley
1 paper
JP
Josef Pleticha
1 paper
Kathryn Ruddy
1 paper

Clinical trials

Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)
Principal investigator · Terminated · Phase 1, Phase 2
Western Regional Medical Center
2015–2017
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
2024–2030
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2023–2033